Timothée Olivier, MD
Verified account This account is verified. Learn more@Timothee_MD
Oncology (sarcoma, H&N, CUP). EBM, Health Policy @HUG_ge (Geneva), @vkprasadlab (UCSF). Geneva Ethics Committee. Co-EiC ESMO Rare Cancers. No COI. Views mine.
426 Following 3K Followers 2.6K Posts
Latest posts 5
Great guest post by @sarojniraula, discussing his recent @JCO_ASCO editorial with Ian Tannock!
@TheWonkologist et al. showed that payments as small as $45 are associated with prescribing decisions involving anticancer drugs.
And these drugs can cost tens of thousands of dollars per month!
Post here: theoncologyshot.com/p/currency-of-…
@TheWonkologist et al. showed that payments as small as $45 are associated with prescribing decisions involving anticancer drugs.
And these drugs can cost tens of thousands of dollars per month!
Post here: theoncologyshot.com/p/currency-of-…
Informative censoring is often seen as too technical, and its impact can be difficult to assess.
In my recent lecture at @MDAnderson_ES, I tried to break it down into more intuitive concepts, using the Breaking-ICE App, an application we developed, with the PATINA trial as an example.
Hope you will like it! @Alfdoc2 @hug_ge @UNIGEnews
In my recent lecture at @MDAnderson_ES, I tried to break it down into more intuitive concepts, using the Breaking-ICE App, an application we developed, with the PATINA trial as an example.
Hope you will like it! @Alfdoc2 @hug_ge @UNIGEnews
5:25
#ESMO26
What a nice evening in Madrid.
Great conversations with inspiring colleagues!
These moments make conferences special!
With Emanuela Romano, @ProfCUBlankNKI, @Rikke_Andersen_, Inge Mansfield Noringriis, @DoniaMarco, Inge Marie Svane & @EvaEllebaek.
What a nice evening in Madrid.
Great conversations with inspiring colleagues!
These moments make conferences special!
With Emanuela Romano, @ProfCUBlankNKI, @Rikke_Andersen_, Inge Mansfield Noringriis, @DoniaMarco, Inge Marie Svane & @EvaEllebaek.
Hey #ESMO26 !
Come to see our 2nd poster, today, 12 am, Hall5!
We often talk about informative censoring for drugs, but what about informative censoring in non-drug oncology trials?
Like any intervention, exercise, behavioral, and supportive care interventions can be burdensome for some patients, potentially leading to dropout.
Our work suggest some level of "burden"-driven informative censoring may happen in such trials + see our sensitivity analyses incl. the CHALLENGE trial!👇
Come to see our 2nd poster, today, 12 am, Hall5!
We often talk about informative censoring for drugs, but what about informative censoring in non-drug oncology trials?
Like any intervention, exercise, behavioral, and supportive care interventions can be burdensome for some patients, potentially leading to dropout.
Our work suggest some level of "burden"-driven informative censoring may happen in such trials + see our sensitivity analyses incl. the CHALLENGE trial!👇
